Status:
RECRUITING
Phosphorylated Tau Levels in Donated Blood
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer&Amp;#39;s Disease
Eligibility:
All Genders
Brief Summary
Alzheimer's disease (AD) is characterized by the accumulation of tau pathology, and blood-based biomarkers such as phosphorylated tau-217 (pTau217) have been identified as sensitive and specific predi...
Detailed Description
Study Type: Observational (Laboratory-based biomarker study; no human intervention) Study Design: * Model: Cross-sectional * Time Perspective: Prospective * Sample Source: Donated human blood plasm...
Eligibility Criteria
Inclusion
- The plasma sample from donators.
Exclusion
- None.
Key Trial Info
Start Date :
August 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT07157839
Start Date
August 28 2025
End Date
December 31 2025
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030